Xu K - Search Results

1

A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer.

Zhang T, Xue W, Wang D, Xu K, Wu L, Wu Y, Zhou Z, Chen D, Feng Q, Liang J, Xiao Z, Hui Z, Lv J, Wang X, Deng L, Wang W, Liu W, Wang J, Zhai Y, Wang J, Bi N, Wang L. Zhang T, et al. Among authors: xu k. Radiother Oncol. 2021 Mar;156:244-250. doi: 10.1016/j.radonc.2020.12.039. Epub 2021 Jan 5. Radiother Oncol. 2021. PMID: 33418003

2

[Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion].

Xu K, Wang Y, Qi J, Zhao L, Wang P. Xu K, et al. Zhongguo Fei Ai Za Zhi. 2018 Jan 20;21(1):16-23. doi: 10.3779/j.issn.1009-3419.2018.01.03. Zhongguo Fei Ai Za Zhi. 2018. PMID: 29357968 Free PMC article. Chinese.

3

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy.

Wang X, Xu L, Yin Z, Wang D, Wang Q, Xu K, Zhao J, Zhao L, Yuan Z, Wang P. Wang X, et al. Among authors: xu k, xu l. Cancer Manag Res. 2018 Oct 2;10:4105-4112. doi: 10.2147/CMAR.S173628. eCollection 2018. Cancer Manag Res. 2018. PMID: 30323666 Free PMC article.

4

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer.

Sun H, Xu L, Wang Y, Zhao J, Xu K, Qi J, Yuan Z, Zhao L, Wang P. Sun H, et al. Among authors: xu k, xu l. Radiat Oncol. 2018 Dec 18;13(1):250. doi: 10.1186/s13014-018-1198-4. Radiat Oncol. 2018. PMID: 30563554 Free PMC article. Clinical Trial.

5

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.

Wang D, Bi N, Zhang T, Zhou Z, Xiao Z, Liang J, Chen D, Hui Z, Lv J, Wang X, Wang X, Deng L, Wang W, Wang J, Wang C, Lu X, Xu K, Wu L, Xue W, Feng Q, Wang L. Wang D, et al. Among authors: xu k. Radiat Oncol. 2019 Jun 13;14(1):106. doi: 10.1186/s13014-019-1259-3. Radiat Oncol. 2019. PMID: 31196118 Free PMC article.

6

CHST15 promotes the proliferation of TE‑1 cells via multiple pathways in esophageal cancer.

Wang X, Cheng G, Zhang T, Deng L, Xu K, Xu X, Wang W, Zhou Z, Feng Q, Chen D, Bi N, Wang L. Wang X, et al. Among authors: xu k, xu x. Oncol Rep. 2020 Jan;43(1):75-86. doi: 10.3892/or.2019.7395. Epub 2019 Oct 30. Oncol Rep. 2020. PMID: 31746400 Free PMC article.

7

Deep Learning Improved Clinical Target Volume Contouring Quality and Efficiency for Postoperative Radiation Therapy in Non-small Cell Lung Cancer.

Bi N, Wang J, Zhang T, Chen X, Xia W, Miao J, Xu K, Wu L, Fan Q, Wang L, Li Y, Zhou Z, Dai J. Bi N, et al. Among authors: xu k. Front Oncol. 2019 Nov 13;9:1192. doi: 10.3389/fonc.2019.01192. eCollection 2019. Front Oncol. 2019. PMID: 31799181 Free PMC article.

8

Efficacy and safety of immune checkpoint inhibitor consolidation after chemoradiation in patients of Asian ethnicity with unresectable stage III non-small cell lung cancer: Chinese multicenter report and literature review.

Zhang T, Xu K, Bi N, Zhang L, Jiang W, Liang J, Deng L, Wang X, Wang J, Wang J, Wang L. Zhang T, et al. Among authors: xu k. Thorac Cancer. 2020 Oct;11(10):2916-2923. doi: 10.1111/1759-7714.13631. Epub 2020 Aug 24. Thorac Cancer. 2020. PMID: 32833338 Free PMC article. Review.

9

Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer.

Xu K, Liang J, Zhang T, Zhou Z, Chen D, Feng Q, Xiao Z, Hui Z, Lu J, Wang X, Deng L, Liu W, Wang J, Zhai Y, Wang J, Bi N, Wang L. Xu K, et al. Thorac Cancer. 2021 Mar;12(6):814-823. doi: 10.1111/1759-7714.13816. Epub 2021 Jan 27. Thorac Cancer. 2021. PMID: 33501781 Free PMC article.

10

The clinical utility of dynamic ctDNA monitoring in inoperable localized NSCLC patients.

Yang Y, Zhang T, Wang J, Wang J, Xu Y, Zhao X, Ou Q, Shao Y, Wang X, Wu Y, Wu L, Xu X, Xu K, Zhao J, Wang L, Bi N. Yang Y, et al. Among authors: xu k, xu x, xu y. Mol Cancer. 2022 May 19;21(1):117. doi: 10.1186/s12943-022-01590-0. Mol Cancer. 2022. PMID: 35590322 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,683 results

Search Page